Zinzino group revenue increased 48% in Q3, compared with the previous year.
The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.
Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.
Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.
Revenues were distributed as follows:
Regions, mSEK
25-Sep
24-Sep
Change
Q3 2025
Q3 2024
Change
YTD 2025
YTD 2024
Change
The Nordics
26.5
25.4
4%
79.6
72.5
10%
235.1
214.0
10%
Central Europe
93.8
48.7
93%
242.8
138.6
75%
657.9
394.4
67%
East Europe
29.4
28.3
4%
89.7
88.3
2%
276.2
279.9
-1%
South & West Europe
50.1
38.0
32%
137.2
104.2
32%
399.2
264.5
51%
The Baltics
8.9
7.2
24%
28.6
21.9
31%
85.3
69.4
23%
North America
41.3
20.3
103%
129.8
52.6
147%
382.1
134.0
185%
Asia-Pacific
21.6
9.6
125%
63.7
22.3
186%
212.7
47.5
348%
Africa
1.9
1.2
58%
5.8
4.0
46%
16.0
10.9
47%
Zinzino
273.5
178.7
53%
777.3
504.4
54%
2264.5
1414.6
60%
Faun Pharma
3.7
5.8
-36%
9.4
28.4
-67%
40.4
79.7
-49%
Zinzino Group
277.2
184.5
50%
786.7
532.8
48%
2304.9
1494.3
54%
Countries in regions:
– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
– Central Europe: Austria, Germany, Switzerland
– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
– The Baltics: Estonia, Latvia, Lithuania
– North America: Canada, USA, Mexico
– Asia-Pacific: Australia, New Zealand, Hong